Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
Aggie Makes Social Media Not Suck
-
Alkeus Pharmaceuticals Receives FDA Rare Pediatric Disease and Fast Track Designations for Gildeuretinol as a Treatment for Stargardt Disease
-
Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form D/A Bain Capital Public Equi
-
KKR Receives Support and Recommendation from FUJI SOFT for Second Tender Offer and Expects to Launch Tender Offer Next Week
-
KKR raises tender offer price for Fuji Soft acquisition
-
Form SC 13G/A NaaS Technology Inc. Filed by: Bain Capital Rise Education IV Cayman Ltd
-
Form SC 13G/A Disc Medicine, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form SC 13G/A BRP Inc. Filed by: Bain Capital Integral Investors II, L.P.
-
Form SC 13G/A Annexon, Inc. Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SC 13G/A AvidXchange Holdings, Filed by: BAIN CAPITAL VENTURE FUND 2014, L.P.
-
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form 10-Q Bain Capital Private For: Sep 30
-
Form 13F-HR BAIN CAPITAL INVESTORS For: Sep 30
-
Form 13F-HR BAIN CAPITAL VENTURE For: Sep 30
-
Form 13F-NT Bain Capital Partners For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-HR Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Partners For: Sep 30
-
Form 13F-NT Bain Capital Venture For: Sep 30
-
Form 13F-NT Bain Capital Fund XI, For: Sep 30
-
Form 13F-NT BAIN CAPITAL VENTURE For: Sep 30
-
Form 13F-NT BAIN CAPITAL VENTURE For: Sep 30
-
Form 13F-NT Bain Capital Venture For: Sep 30
-
Form 13F-NT Bain Capital Fund XII, For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-HR Bain Capital Public Equi For: Sep 30
-
Form 13F-HR Bain Capital Public Equi For: Sep 30
-
Form 13F-HR Bain Capital Credit, LP For: Sep 30
-
Exclusive-Blackstone eyes 20% stake in India Haldiram's snacks at $8 billion valuation, sources say
-
The Vistria Group announces Senior Appointments to Support Continued Growth
-
Factbox-Seven & i's reported offer and the biggest management buyouts to date
-
Race for Japanese 7-Eleven owner heats up with founding family bid
-
Franklin Covey (FC) Appoints Holly Procter as Chief Revenue Officer
-
FranklinCovey Appoints Holly Procter to the Role of Chief Revenue Officer
-
JenaValve Presents ALIGN-AR 2-Year Follow-Up Data at TCT 2024 and Announces Commencement of ARTIST Randomized Controlled Trial (RCT)
-
Emerald Bay Risk Solutions Launches Inaugural Casualty Program with Vanderbilt
-
Carlyle, Warburg among investment firms hunting talent in Japan as deals boom
-
Bain further delays Fuji Soft tender offer plans, awaits company approval
-
Northflank Raises $22M to Simplify App and Database Deployment in Your Cloud
-
Japanese chipmaker Kioxia files for IPO; sources say it's targeting December
-
Envestnet Reports Third Quarter 2024 Financial Results
-
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update
